Sawyer & Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Buy
11,647
+4
+0% +$4.09K 4.69% 5
2026
Q1
$10.7M Sell
11,643
-107
-0.9% -$108K 4.12% 4
2025
Q4
$12.6M Sell
11,750
-76
-0.6% -$72.7K 4.47% 5
2025
Q3
$9.22M Buy
11,826
+179
+2% +$133K 3.48% 6
2025
Q2
$14M Sell
11,647
-283
-2% -$220K 4.69% 5
2025
Q1
$9.85M Sell
11,930
-224
-2% -$186K 3.98% 2
2024
Q4
$9.38M Buy
12,154
+5,689
+88% +$4.71M 3.47% 6
2024
Q3
$5.73M Buy
6,465
+27
+0.4% +$24.3K 2.12% 10
2024
Q2
$5.83M Buy
6,438
+11
+0.2% +$8.8K 2.32% 7
2024
Q1
$5M Sell
6,427
-18
-0.3% -$12.8K 2% 16
2023
Q4
$3.76M Sell
6,445
-265
-4% -$155K 1.66% 19
2023
Q3
$3.6M Buy
6,710
+25
+0.4% +$12.9K 1.68% 21
2023
Q2
$3.13M Buy
6,685
+11
+0.2% +$4.61K 1.43% 20
2023
Q1
$2.45M Buy
+6,674
New +$2.25M 1.32% 29

Other funds holding LLY

Sawyer & Company's LLY Position: Q2 2026 in Review

Sawyer & Company increased its Eli Lilly (LLY) stake by 0.03% in Q2 2026, buying an estimated $4.09K and bringing the position to 11,647 shares worth $14M. The position accounts for 4.69% of the portfolio, ranked #5.

Sawyer & Company first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sawyer & Company held 11,647 shares of Eli Lilly worth $14M as of Q2 2026.
  • Sawyer & Company bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 4.69% of Sawyer & Company's portfolio in Q2 2026, its #5 holding.
  • Sawyer & Company first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.